This course naturally reflects the essential multidisciplinary management of prostate cancer, which requires exchange and consultation between all the players involved: urologists, radiotherapists, medical oncologists, imaging physicians, pathologists, biologists, whose Common Shared Objective (CSO) is the patient.
Opening times
From 10 September 2025 until 13 September 2025 - Open everyday
